Recent studies on the biological action of parathyroid hormone (PTH)-related peptide (PTHrP) and PTH/PTHrP receptor in cartilage and bone by Amizuka, Norio et al.
Histol Histopathol (2000) 15: 957-970 
http:l/www.ehu.es/histol-histopathol 
Invited Revie W 
Histology and 
Histo pathology 
Cellular and Molecular Biology 
Recent studies on the biological action of 
parathyroid hormone (PTH)-related peptide (PTHrP) 
and PTH/PTHrP receptor in cartilage and bone 
N. Amizukal, J.E. Henderson2, J.H. White3, A.C. Karaplis2, D. Goltzman4, T. Sasaki 1 and H. Ozawal 
1Department of Oral Anatomy, Niigata University Faculty of Dentistry, Niigata, Japan, 
2Endocrine Division, S.M.M.B.D.-Jewish General Hospital, Lady Davis Institute for Medical Research, Montreal, Canada, 
3Department of Physiology and Medicine, McGill University, Montreal, Canada and 
4Department of Medicine, McGill University, Calcium Research Laboratory, Royal Victoria, Hospital, Montreal, Canada 
Summary. Mice with a targeted deletion of parathyroid 
hormone (PTH)-related peptide (PTHrP) develop a form 
of dyschondroplasia resulting from diminished 
proliferation and premature maturation of chondrocytes. 
Abnormal, heterogeneous populations of chondrocytes at 
different stages of differentiation were seen in the 
hypertrophic zone of the mutant growth plate. Although 
the homozygous null animals die within several hours of 
birth, mice heterozygous for PTHrP gene deletion reach 
adulthood, at which time they show evidence of 
osteopenia. Therefore, PTHrP appears to modulate cell 
proliferation and differentiation in both the pre and post 
natal period. PTHIPTHrP receptor expression in the 
mouse is controlled by two promoters. We recently 
found that, while the downstream promoter controls 
PTHIPTHrP receptor gene expression in bone and 
cartilage, it is differentially regulated in the two tissues. 
1a,25-dihydroxyvitamin D3 downregulated the activity 
of the downstream promoter in osteoblasts, but not in 
chondrocytes, both in vivo and in vitro. Most of the 
biological activity of PTHrP is thought to be mediated 
by binding of its amino terminus to the PTHIPTHrP 
receptor. However, recent evidence suggests that amino 
acids 87-107, outside of the amino terminal binding 
domain, act as a nucleolar targeting signal. Chondrocytic 
cell line, CFK2, transfected with wild-type PTHrP 
cDNA showed PTHrP in the nucleoli as well as in the 
secretory pathway. Therefore, PTHrP appears to act as a 
bifunctional modulator of both chondrocyte proliferation 
and differentiation, through signal transduction linked to 
the PTH/PTHrP receptor and by its direct action in the 
nucleolus. 
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Introduction 
Parathyroid hormone (PTH)-related peptide (PTHrP) 
was first identified as a tumor derived factor that caused 
hypercalcemia in patients with a variety of malignancies 
(Burtis et al., 1987; Strewler et al., 1987; Suva et al., 
1987). The high homology within the extreme amino 
termini of PTH and PTHrP permits them to bind to the 
common receptor, PTHIPTHrP receptor (Jiippner et al., 
1991) on target cells in kidney and bone. Consequently, 
systemic PTHrP, released by the tumor, mimics the 
biological activity of PTH (Horiuchi et al., 1987; Kemp 
et al., 1987; Rabbani et al., 1988; Thompson et al., 
1988). However, unlike PTH, which i s  the major 
regulator of calcium homeostasis, PTHrP does not 
circulate in significant quantities under normal 
circumstances. Rather, in view of the widespread 
expression of PTHrP and its receptor in a number of fetal 
and adult tissues (Ureiia et al., 1993). It is thought to act 
as a local regulator of cell growth and differetiation 
(Merendino et al., 1986; Ikeda et al., 1988; Thiede and 
Rodan, 1988, Dmcker et al., 1989; Thiede et al., 1990; 
Moseley et al., 1991; Kaiser et al., 1992, 1994; Deftos et 
al., 1993). PTHrP is expressed during embryogenesis in 
mural trophoblast cells, in extra-decidual uterine stroma, 
in placenta, in the epithelial cells of the dental lamina 
including ameloblasts, in hair follicles, in keratinocytes, 
in nasal epithelial cell and in the membranous labyrinth, 
in epithelial cells in the lung, and in cartilage and bone 
(Senior et al., 1990, Lee et al., 1994). 
Our studies using a mouse with targeted deletion of 
the PTHrP gene, developed by Karaplis et al. in 1994, 
demonstrated that PTHrP plays a key role in chondro- 
osteogenesis (Karaplis et al., 1994). Mice homozygous 













